Team:Trieste/data

From 2012.igem.org

(Difference between revisions)
(fix links)
 
(36 intermediate revisions not shown)
Line 3: Line 3:
<div id="body">
<div id="body">
-
    <div id="container"> <!-- start container -->  
+
<div id="container"> <!-- start container -->  
-
        </html>{{Team:Trieste/menu}}<html>
+
</html>{{Team:Trieste/menu}}<html>
<div id="content"> <!-- start content -->
<div id="content"> <!-- start content -->
-
        <h1 id="h1_lf" class="main_tit"><div>Data</div></h1>
+
<h1 id="h1_lf" class="main_tit"><div>Data</div></h1>
-
            <h1 id="h1_rt" class="main_tit"><div>More</div></h1>
+
<h1 id="h1_rt" class="main_tit"><div>More</div></h1>
-
            <div id="box_main"> <!-- start box_main -->
+
<div id="box_main"> <!-- start box_main -->
-
                <div class="box_contenuti">
+
<div class="box_contenuti">
-
<h1>An overview on our system</h1>
+
<h1>An overview of our system</h1>
-
<h2></h2>
+
<center><img src="https://static.igem.org/mediawiki/2012/a/a8/Progetto_copia.jpg" width="700px"/></center>
-
<br/>
+
<p>
-
<center><img src="https://static.igem.org/mediawiki/2012/a/a8/Progetto_copia.jpg" width="700px"/></center>
+
<strong>This is a diagram summarising our system. It consists of two parts: the production of Ab against NoroVirus and the gene guard.</strong><br/>
-
<br/>
+
Concerning the gene guard, CymR inhibits the T5 Cumate Operator Promoter avoiding the production of the T4 Holin (permeabilizes the cytoplasmatic membrane) and the LL 37 cathelicidin (human antimicrobial peptide able to disrupt the outer membrane).<br/>
-
<br/>
+
When the cumate is given, it binds and inactivates the CymR, derepressing the T5 Cumate Operator Promoter and allowing the expression of T4 Holin, that permeabilizes the cytoplasmatic membrane, allowing the secretion of LL 37 that disrupt the outer membrane.<br/>
-
<h2> Our favourite parts:</h2>
+
Moreover, the horizontal transfer from our Nissle into another bacteria is avoided thanks to our gene guard. The receiving bacteria do not produce the CymR repressor, so the T5 Cumate Operator Promoter is activated allowing T4 Holin and LL 37 expression. Bacteria die!
-
                          <table>
+
</p>
-
    <tbody>
+
<h2> Our favourite parts:</h2>
-
<tr>
+
<table>
-
    <td><img src="http://mmcpoker.net/images/cuori.gif" width="50px"/></a></td>  
+
<tbody>
-
    <td><h3>BBa_K875001, T5 cumate operator:</h3>  
+
<tr>
-
<br/>
+
<td><img src="http://mmcpoker.net/images/cuori.gif" width="50px"/></td>  
-
We have dimontrated that it is a very strong and strictly regulated promoter. Thanks to its rapid reactivity it's one of the first candidate for the expression and production of toxin in case of necessity.<br/>
+
<td>
-
<br/></td>
+
<h3><a href="https://2012.igem.org/Team:Trieste/parts/1">BBa_K875001</a>, T5 cumate operator:</h3>  
-
                </tr>
+
We demonstrated that this promoter is very strong and strictly regulated. Thanks to its rapid responsiveness it's one of the first candidates for the toxin expression and production in case of necessity.
-
<tr>
+
</td>
-
    <td><img src="http://mmcpoker.net/images/cuori.gif" width="50px"/></a></td>  
+
</tr>
-
    <td><h3>BBa_K875003, CymR:</h3>
+
<tr>
-
<br/>
+
<td><img src="http://mmcpoker.net/images/cuori.gif" width="50px"/></td>  
-
We have succesfully expressed the CymR. We have also showed his stringency as repressor of the T5 Cumate Operator that makes the all system a very useful mechanism for an high specificity expression.
+
<td>
-
<br/><br/></td>
+
<h3><a href="https://2012.igem.org/Team:Trieste/parts/3">BBa_K875003</a>, CymR:</h3>
-
                </tr>
+
We expressed succesfully the CymR. We also showed his stringency as repressor of the T5 Cumate Operator. Together, CymR and T5 Cumate Operator, create a safe and tightly regulated gene guard system, which keeps under control the bacterial growth.
-
<tr>
+
</td>
-
    <td><img src="http://mmcpoker.net/images/cuori.gif" width="50px"/></a></td>  
+
</tr>
-
    <td><h3>BBa_K875004, LPP-OmpA-scFv:</h3>  
+
<tr>
-
<br/>
+
<td><img src="http://mmcpoker.net/images/cuori.gif" width="50px"/></td>  
-
We have verified the production of this protein at high yield. OmpA is a very powerful method for displaying proteins on the external membrane, in this case the antibody scFv 54.6.<br/><br/></td>
+
<td>
-
                </tr>
+
<h3><a href="ttp://2012.igem.org/Team:Trieste/parts/4">BBa_K875004</a>, LPP-OmpA-scFv:</h3>  
-
<tr>
+
We verified the production of this protein at high yield. LPP-OmpA system is a very powerful method for protein display on the outer membrane, in this case the antibody scFv 54.6.
-
<br/>
+
</td>
-
<br/>
+
</tr>
-
<br/></td>
+
</tbody>
-
                </tr>
+
</table>
-
                            </tbody>
+
<h2>The part we improved:</h2>
-
                          </table>
+
<table>
-
 
+
<tbody>
-
 
+
<tr>
-
                                   
+
<td><img src="http://www.superscommesse.it/images/stella_piena.jpg" width="50px"/></a></td>  
-
 
+
<td>
-
 
+
<h3><a href="https://2012.igem.org/Team:Trieste/parts/10">BBa_K875020</a>, Beta-Glucosidase (Osaka 2010):</h3>  
-
 
+
This composite part is developed by previous work by UNITS iGEM team 2011 and Edinburgh team 2011. We improved and characterized this part demonstrating its efficiency.
-
 
+
</td>
-
<h2>The part we have improved:</h2>
+
</tr>
-
<br/>
+
</tbody>
-
<h3>BBa_K875020, Beta-Glucosidase (Osaka 2010):</h3>
+
</table>
-
<br/>
+
<h2>Other parts that we developed:</h2>
-
This composite part is developed by previous work by UNITS iGEM team 2011 and Edinburgh team 2011. We improved and characterized this part demonstrating its efficiency.
+
<p>
-
<br/>  
+
<h3><a href="https://2012.igem.org/Team:Trieste/parts/2">BBa_K875002</a>, T5 Lac Operator:</h3>
-
<br/>
+
We showed that this promoter comes very handy for protein expression tests.
-
 
+
</p>
-
 
+
-
<h2>Other parts that we developed:</h2>
+
<p>
-
<br/>
+
<h3><a href="https://2012.igem.org/Team:Trieste/parts/5">BBa_K875005</a>, LPP-OmpA-SIP:</h3>
-
<h3>BBa_K875002, T5 Lac Operator:</h3>
+
We designed this biobrick containing SIP as a valid alternative to scFv, because SIP confers bivalent binding properties to the antibody.
-
<br/>
+
</p>
-
We have shown that this promoter is a very useful biobricks in the primary testing of protein expression thanks to his handiness.
+
<p>
-
<br/>
+
<h3><a href="https://2012.igem.org/Team:Trieste/parts/6">BBa_K875006</a>, PelB-scFv:</h3>
-
<br/>
+
We created this composit biobrick to use as a system which allows secretion of proteins, in this case the antibody, first into periplasm and then extracellularly.
-
<h3>BBa_K875005, LPP-OmpA-SIP:</h3>
+
</p>
-
 
+
<p>
-
 
+
<h3><a href="https://2012.igem.org/Team:Trieste/parts/7">BBa_K875007</a>, PelB-SIP:</h3>
-
 
+
We built this biobrick (secreted version of SIP) because soluble form of SIP plays an important role in enteric infections.
-
                </div>
+
</p>
-
            </div> <!-- end box_main -->
+
<p>
-
            <div id="box_right"> <!-- start box_right -->
+
<h3><a href="https://2012.igem.org/Team:Trieste/parts/8">BBa_K875008</a>, Tse2 toxin:</h3>
-
            <ul id="sub_menu">
+
We demonstrated that this composit is an important suicide mechanism able to arrest the growth of prokaryotic cells.
-
                <li><a href="https://2012.igem.org/Team:Trieste/project/mainres">Main Results</a></li>
+
</p>
-
                    <li class="select"><a href="#">Sotto menu 2</a></li>
+
<p>
-
                    <li><a href="#">Sotto menu 3</a></li>
+
<h3><a href="https://2012.igem.org/Team:Trieste/parts/9">BBa_K875009</a>, LL 37:</h3>
-
                    <li><a href="#">Sotto menu 4</a></li>
+
The LL 37 is a very powerful human antimicrobial peptide that kills bacteria.
-
                    <li><a href="#">Sotto menu 5</a></li>
+
We are developing a new construct combining the toxin with the T4 holin which breaks the inner membrane allowing the  LL 37 to reach his target.
-
                </ul>
+
</p>
-
                <img src="https://static.igem.org/mediawiki/2012/b/b0/Team_trieste.jpg" alt="Team iGEM 2012" id="igem_team" />
+
</div>
-
                <div class="box_contacts">
+
</div> <!-- end box_main -->
-
<h2>Contact us</h2>
+
<div id="box_right"> <!-- start box_right -->
-
<p>For other information, write to:</p>
+
<ul id="sub_menu">
-
                    <a href="mailto:igem2012@gmail.com" class="btn">igem2012@gmail.com</a>
+
<li class="select"><a href="https://2012.igem.org/Team:Trieste/data">Data</a></li>
-
                    <div class="social">
+
</ul>
-
                    Follow us also:
+
<img src="https://static.igem.org/mediawiki/2012/b/b0/Team_trieste.jpg" alt="Team iGEM 2012" id="igem_team" />
-
<a href="https://www.facebook.com/IGEMUNITS?ref=ts" target="_blank"><img src="https://static.igem.org/mediawiki/2012/f/f4/Ico_fb.png" alt="Facebook" class="fb" /></a>
+
<div class="box_contacts">
-
                        <a href="https://twitter.com/igemunits" target="_blank"><img src="https://static.igem.org/mediawiki/2012/2/21/Ico_twitter.png" alt="twitter" class="tw" /></a>
+
<h2>Contact us</h2>
-
                    </div>
+
<p>For other information, write to:</p>
-
                </div>
+
<a href="mailto:igem2012@gmail.com" class="btn">igem2012@gmail.com</a>
-
            </div> <!-- end box_right -->
+
<div class="social">
-
            </html>{{Team:Trieste/footer}}<html>
+
Follow us also:
-
        <!-- end content is included in template -->
+
<a href="https://www.facebook.com/IGEMUNITS?ref=ts" target="_blank"><img src="https://static.igem.org/mediawiki/2012/f/f4/Ico_fb.png" alt="Facebook" class="fb" /></a>
-
    </div> <!-- end container -->
+
<a href="https://twitter.com/iGEMTrieste" target="_blank"><img src="https://static.igem.org/mediawiki/2012/2/21/Ico_twitter.png" alt="twitter" class="tw" /></a>
 +
</div>
 +
</div>
 +
</div> <!-- end box_right -->
 +
</html>{{Team:Trieste/footer}}<html>
 +
<!-- end content is included in template -->
 +
</div> <!-- end container -->
</div>
</div>
</html>
</html>

Latest revision as of 12:23, 15 October 2012

Data

More

An overview of our system

This is a diagram summarising our system. It consists of two parts: the production of Ab against NoroVirus and the gene guard.
Concerning the gene guard, CymR inhibits the T5 Cumate Operator Promoter avoiding the production of the T4 Holin (permeabilizes the cytoplasmatic membrane) and the LL 37 cathelicidin (human antimicrobial peptide able to disrupt the outer membrane).
When the cumate is given, it binds and inactivates the CymR, derepressing the T5 Cumate Operator Promoter and allowing the expression of T4 Holin, that permeabilizes the cytoplasmatic membrane, allowing the secretion of LL 37 that disrupt the outer membrane.
Moreover, the horizontal transfer from our Nissle into another bacteria is avoided thanks to our gene guard. The receiving bacteria do not produce the CymR repressor, so the T5 Cumate Operator Promoter is activated allowing T4 Holin and LL 37 expression. Bacteria die!

Our favourite parts:

BBa_K875001, T5 cumate operator:

We demonstrated that this promoter is very strong and strictly regulated. Thanks to its rapid responsiveness it's one of the first candidates for the toxin expression and production in case of necessity.

BBa_K875003, CymR:

We expressed succesfully the CymR. We also showed his stringency as repressor of the T5 Cumate Operator. Together, CymR and T5 Cumate Operator, create a safe and tightly regulated gene guard system, which keeps under control the bacterial growth.

BBa_K875004, LPP-OmpA-scFv:

We verified the production of this protein at high yield. LPP-OmpA system is a very powerful method for protein display on the outer membrane, in this case the antibody scFv 54.6.

The part we improved:

BBa_K875020, Beta-Glucosidase (Osaka 2010):

This composite part is developed by previous work by UNITS iGEM team 2011 and Edinburgh team 2011. We improved and characterized this part demonstrating its efficiency.

Other parts that we developed:

BBa_K875002, T5 Lac Operator:

We showed that this promoter comes very handy for protein expression tests.

BBa_K875005, LPP-OmpA-SIP:

We designed this biobrick containing SIP as a valid alternative to scFv, because SIP confers bivalent binding properties to the antibody.

BBa_K875006, PelB-scFv:

We created this composit biobrick to use as a system which allows secretion of proteins, in this case the antibody, first into periplasm and then extracellularly.

BBa_K875007, PelB-SIP:

We built this biobrick (secreted version of SIP) because soluble form of SIP plays an important role in enteric infections.

BBa_K875008, Tse2 toxin:

We demonstrated that this composit is an important suicide mechanism able to arrest the growth of prokaryotic cells.

BBa_K875009, LL 37:

The LL 37 is a very powerful human antimicrobial peptide that kills bacteria. We are developing a new construct combining the toxin with the T4 holin which breaks the inner membrane allowing the LL 37 to reach his target.

Team iGEM 2012

Contact us

For other information, write to:

igem2012@gmail.com
Università degli studi di Trieste ICGEB Illy Fondazione Cassa di Risparmio
iGEM 2012 iGEM 2012 iGEM 2012 iGEM 2012 iGEM 2012 iGEM 2012
HTML Hit Counter

Retrieved from "http://2012.igem.org/Team:Trieste/data"